These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 16553512

  • 1. Is there an optimal corticosteroid regimen for the management of an acute exacerbation of chronic obstructive pulmonary disease?
    Vondracek SF, Hemstreet BA.
    Pharmacotherapy; 2006 Apr; 26(4):522-32. PubMed ID: 16553512
    [Abstract] [Full Text] [Related]

  • 2. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM, White CM, Coleman CI.
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [Abstract] [Full Text] [Related]

  • 3. Systemic corticosteroids in chronic obstructive pulmonary disease: an overview of Cochrane systematic reviews.
    Wood-Baker R, Walters J, Walters EH.
    Respir Med; 2007 Mar; 101(3):371-7. PubMed ID: 16962307
    [Abstract] [Full Text] [Related]

  • 4. Steroids in acute exacerbations of chronic obstructive pulmonary disease: are nebulized and systemic forms comparable?
    Gunen H, Mirici A, Meral M, Akgün M.
    Curr Opin Pulm Med; 2009 Mar; 15(2):133-7. PubMed ID: 19532028
    [Abstract] [Full Text] [Related]

  • 5. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL, Baker EL, Coleman CI.
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [Abstract] [Full Text] [Related]

  • 6. Systemic corticosteroid for COPD exacerbations, whether the higher dose is better? A meta-analysis of randomized controlled trials.
    Cheng T, Gong Y, Guo Y, Cheng Q, Zhou M, Shi G, Wan H.
    Clin Respir J; 2013 Oct; 7(4):305-18. PubMed ID: 23072733
    [Abstract] [Full Text] [Related]

  • 7. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.
    Akazawa M, Biddle AK, Stearns SC.
    Clin Ther; 2008 Oct; 30 Spec No():1003-16. PubMed ID: 18640475
    [Abstract] [Full Text] [Related]

  • 8. Clinical inquiries. Do systemic corticosteroids lessen symptoms in acute exacerbations of COPD?
    McDiarmid T, Mackler L, Briscoe D.
    J Fam Pract; 2003 Dec; 52(12):979-80. PubMed ID: 14653988
    [No Abstract] [Full Text] [Related]

  • 9. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.
    Woodle ES, First MR, Pirsch J, Shihab F, Gaber AO, Van Veldhuisen P, Astellas Corticosteroid Withdrawal Study Group.
    Ann Surg; 2008 Oct; 248(4):564-77. PubMed ID: 18936569
    [Abstract] [Full Text] [Related]

  • 10. Tapering of corticosteroid therapy following exacerbation of asthma. A randomized, double-blind, placebo-controlled trial.
    Lederle FA, Pluhar RE, Joseph AM, Niewoehner DE.
    Arch Intern Med; 1987 Dec; 147(12):2201-3. PubMed ID: 3318751
    [Abstract] [Full Text] [Related]

  • 11. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial.
    Leuppi JD, Schuetz P, Bingisser R, Bodmer M, Briel M, Drescher T, Duerring U, Henzen C, Leibbrandt Y, Maier S, Miedinger D, Müller B, Scherr A, Schindler C, Stoeckli R, Viatte S, von Garnier C, Tamm M, Rutishauser J.
    JAMA; 2013 Jun 05; 309(21):2223-31. PubMed ID: 23695200
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Systemic Corticosteroid and Antibiotic Use in Hospitalized Patients With Chronic Obstructive Pulmonary Disease Exacerbation.
    Petite SE, Murphy JA.
    Ann Pharmacother; 2019 Feb 05; 53(2):144-150. PubMed ID: 30175589
    [Abstract] [Full Text] [Related]

  • 14. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
    Chen AM, Bollmeier SG, Finnegan PM.
    Ann Pharmacother; 2008 Dec 05; 42(12):1832-42. PubMed ID: 18957624
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Circadian-rhythm differences among emergency department patients with chronic obstructive pulmonary disease exacerbation.
    Tsai CL, Brenner BE, Camargo CA.
    Chronobiol Int; 2007 Dec 05; 24(4):699-713. PubMed ID: 17701681
    [Abstract] [Full Text] [Related]

  • 17. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP.
    Am J Med; 2006 Oct 05; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [Abstract] [Full Text] [Related]

  • 18. Reduction of corticosteroid use in outpatient treatment of exacerbated COPD - Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial).
    Urwyler P, Boesing M, Abig K, Cattaneo M, Dieterle T, Zeller A, Bachler H, Markun S, Senn O, Merlo C, Essig S, Ullmer E, Rutishauser J, Schuurmans MM, Leuppi JD.
    Trials; 2019 Dec 16; 20(1):727. PubMed ID: 31842993
    [Abstract] [Full Text] [Related]

  • 19. The benefits of long-term systemic antimicrobial therapy in chronic obstructive pulmonary disease.
    Berim I, Sethi S.
    Ther Adv Respir Dis; 2011 Jun 16; 5(3):207-16. PubMed ID: 21378062
    [Abstract] [Full Text] [Related]

  • 20. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
    Nseir S, Di Pompeo C, Cavestri B, Jozefowicz E, Nyunga M, Soubrier S, Roussel-Delvallez M, Saulnier F, Mathieu D, Durocher A.
    Crit Care Med; 2006 Dec 16; 34(12):2959-66. PubMed ID: 17012911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.